Review Papers - TANAKA HIROSHI
-
Inflammatory chemokine expression via toll-like receptor 3 signaling in normal human mesangial cells
Tanaka H and Imaizumi T
Clinical and Developmental Immunology 2013 2013.6
-
Treatment of young patients with lupus nephritis using calcineurin inhibitors.
Tanaka H, Tsuruga K, Watanabe S, Aizawa-Yashiro T, Imaizumi T.
World Journal of Nephrology 1 ( 6 ) 177 - 183 2012.12
-
Mizoribine in the treatment of pediatric-onset glomerular disease: Revisit its beneficial effects from the histological standpoint
Tanaka H, Tsuruga K, Imaizumi T
World Journal of Pediatrics 11 ( 2 ) 108 - 112 2015.5
-
Mesangial viral and psuedoviral immunity: possible involvement in the pathogenesis of pediatric-onset active lupus nephritis
Tanaka H, Imaizumi T
Journal of Arthritis 4 ( 4 ) 183 - 186 2015.12
-
Efficacy and safety of tacrolimus in 101 consecutive patients with rheumatoid arthritis: a possible alternative treatment to methotrexate?
Hiroshi Tanaka
International Journal of Clinical Rheumatology 5 ( 5 ) 519 - 521 2010.10
-
Retinoic acid-inducible gene-I (RIG-I) and glomerular diseases: possible involvement of RIG-I in the glomerular inflammatory reaction.
Tanaka H, Tsuruga K, Imaizumi T.
Res Adv Nephrol Dial Transplant 1 ( 1 ) 1 - 8 2011.6
-
Treatment of pediatric-onset lupus nephritis: A proposal of optimal therapy
Tanaka H, Joh K, Imaizumi T
Clin Exp Nephrol 21 ( 5 ) 755 - 763 2017.10
-
Expression of retinoic acid-inducible gene-I (RIG-I) in cultured human mesangial cells: A possible involvement of RIG-I in the inflammatory reactions
Hiroshi Tanaka, Tomomi Aizawa-Yashiro, Eishin Oki, Kazushi Tsuruga, Tadaatsu Imaizumi
Japanese Journal of Pediatric Nephrology 23 ( 2 ) 141 - 149 2010.11
-
Immunosuppressive therapy for pediatric rheumatic diseases
Hiroshi Tanaka
Inflammation & Immunity 14 ( 4 ) 96 - 103 2006.6
-
Mizoribine and its clinical use for patients with glomerular disease.
Hiroshi Tanaka
Kidney and Dialysis (Tokyo) 76 ( 6 ) 850 - 854 2014.6
-
Membranous nephropathy
Hiroshi Tanaka
( 53 ) 522 - 525 2022.1
-
流行性耳下腺炎 (ムンプス)ワクチン定期接種化の必要性
田中 完
学校保健年報 56 1 - 3 2021.10
-
Toll-like receptor 3 signaling and human glomerular endothelial cells
Hiroshi Tanaka, Tadaatsu Imaizumi
Journal of Experimental Nephrology 1 ( 1 ) 9 - 11 2020.8
-
Orthostatic proteinuria revisted: New clinical impact on the "old" clinical entity?
Hiroshi Tanaka
Annals of Trasnlational Medicine 8 ( 13 ) 814 - 816 2020.7
-
Review of Antiviral innate immunity disturbs podocyte cell function
Hiroshi Tanaka
Japanese Journal of Pediatric Nephrology 28 ( 1 ) 81 - 82 2015.4
-
mRNA expression of proinflammatory cytkines/chemokines induced by "viral infections" in urinary sediment from patients with IgA immunocomplex-mediated glomerulonephritis
Tsuruga K, Tanaka H
Jpn J Pediatr Nephrol 26 ( 2 ) 245 - 249 2013.11
-
Innate immune reactions against RNA viruses in renal mesangial cells.
Imaizumi T, Aizawa T, Tanaka H, Sato F, Xing F, Matsumiya T, Yoshida H, Sato K.
Hirosaki Medical Journal 64 ( Supple ) S70 - S73 2013.4
-
Treatment of lupus nephritis
Yumura W, Okada M, Hiromura K, Tanaka H.
Inflammation & Immunity (Tokyo) 20 ( 4 ) 419 - 429 2012.6
-
Evaluation of glomerular lseion in patients with CKD using mRNA expression of functional molecules in urinary sediment
Tanaka H, Tsuruga K, Yoshida H, Imaizumi T
Proceeding of Okinaka Memorial Institute for Medical Reseach 38 ( 1 ) 54 - 57 2012.6
-
Involvement of retinoic acid-inducible gene-I (RIG-I) in rheumatoid arthritis and lupus nephritis.
Imaizumi T, Tanaka H, Uesato R, Tsugawa K, Matsumiya T, Yoshida H, Ishibashi Y, Satoh K
Hirosaki Med J 62 ( Suppl. ) S46 - S49 2011.10